Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CellCept Dose Adjustment in Renal Transplant Recipients
NCT00737659Phase 4Unknown
- Sponsor
- Rabin Medical Center
- Start
- Aug 2008
- Primary completion
- Aug 2011
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of mycophenolate mofetil in renal transplant rejection (RTR), sponsored by Rabin Medical Center. Status: unknown.
02
Drugs
mycophenolate mofetil
03
Conditions
renal transplant rejection (RTR)
Beyond the preview
Go deeper on NCT00737659.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00737659.